ARTICLE | Product Development
Ortho becomes second to receive EUA for COVID-19 antibody assay
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
April 16, 2020 1:30 AM UTC
Updated on Apr 16, 2020 at 4:28 AM UTC
Ortho has become the second company after Cellex to receive Emergency Use Authorization from FDA for a COVID-19 antibody assay.
Ortho Clinical Diagnostics Inc.’s test can be run on its VITROS systems. The company said that it has shipped a limited quantity of tests to high priority areas, and expects full production in the coming weeks. The company plans to have several million tests manufactured over the next month...